Showing 821 - 830 of 830 for "Pharmaceutical" with applied filters
02 July 2018 by
At the end of April 2018, Advocate General (AG) Wathelet handed down an advisory opinion regarding the first of three recent referrals to the CJEU (C-121/17). This concerns the interpretation of Article 3(a) of Regulation (EC) No 469/2009.
01 June 2018 by
Cialis® is a pharmaceutical product for the treatment of erectile dysfunction developed by Lilly ICOS, a joint venture of ICOS Corporation and Eli Lilly and Company.
01 June 2018 by
A common dilemma for inventors and applicants before the European Patent Office is whether an invention is sufficiently mature for a patent application to be filed.
01 June 2018 by
China announced a huge government reshuffle programme. The sweeping government restructuring programme was said to be the largest reform since the end of the Mao Zedong era in the 1970s
19 May 2018 by
Isabella Cardozo, Hannah Fernandes and Rafael Rocha of Daniel Legal and IP Strategy evaluate the benefits of judicial appeals and stress the importance of agreements which are effective in Brazil
02 April 2018 by
This roundup features Awapatent, Covington & Burling, Dentons, EIP, Eversheds Sutherland, Gowling WLG, Hoyng Rokh Monegier, Mewburn Ellis, Pinsent Masons, Reddie & Grose, Spruson & Ferguson and Véron & Associés
14 July 2017 by
Reputation, expertise and costs are the top three considerations for in-house counsel hiring outside IP advisers, according to a research report by IP STARS
10 July 2017 by
China is big. China is powerful. And now, China may be the best place in the world to file a patent lawsuit, says Erick Robinson of Beijing East IP
26 April 2017 by
This roundup features Armstrong Teasdale, Brinks Gilson & Lione, Eckert Seamans Cherin & Mellott, FisherBroyles, Greenspoon Marder, Mintz Levin, Lewis Roca Rothgerber Christie and Troutman Sanders; plus other people moves reported by Managing IP.
18 August 2016 by
New IP partners at Paul Hastings , Davies Collison Cave, Gibson Dunn & Crutcher and VLP Law Group